Analyze the therapeutic effect of midostaurin and the latest market price in 2025
Midostaurin (Midostaurin) is a new type of targeted anti-tumor drug that is widely used to treat acute myeloid leukemia (AML), especially for those patients with FLT3 gene mutations. With the deepening of medical research, midostaurin has demonstrated significant clinical therapeutic effects, bringing new hope to many patients. This article will discuss the mechanism of action of midostaurin and its market price in detail to provide patients with more comprehensive information.

The main mechanism of action of midostaurin is to inhibit the activity ofFLT3 tyrosine kinase, thereby effectively preventing the growth and spread of cancer cells. In patients with FLT3 mutation-positive acute myeloid leukemia, the drug can significantly improve treatment efficacy and survival rates. Research shows that compared with traditional chemotherapy, midostaurin combined with chemotherapy can significantly extend patients' disease-free survival and overall survival. This superior efficacy makes Midostaurin attract much attention in the medical community.
In addition to the treatment of acute myeloid leukemia, midostaurin has also been used in clinical trials of some other hematological tumors, and its potential application prospects are constantly expanding. However, the use of midostaurin is not without challenges, and the financial burden of the drug has become a major problem faced by many patients. The original drug Midostaurin has not yet been seen on the Chinese market, and its price is naturally unknown. However, in the international market, European, Turkish and Indian versions of midostaurin are available. The common specification is 25mg*112 tablets. The selling price of each box may vary between RMB 10,000 and RMB 70,000 due to exchange rate fluctuations. At the same time, more affordable generic drugs can also be found on the market. For example, the products produced by India's BDR pharmaceutical factory only cost about 9,000 yuan per box, and their drug ingredients are almost the same as the original drugs.
Reference materials:https://en.wikipedia.org/wiki/Midostaurin
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)